Close
APE 2026

Industry Updates

Kazie receives FDA approval for its GDC- 0084

Kazia Therapeutics Limited , an Australian biotechnology company dedicated to the field of oncology, is pleased to announce that the FDA of the United States...

Richard Wolf Announces the Opening of New Office...

Richard Wolf, answering strong global demand for its high-performance endoscopic technology services, today announced plans to expand in Southeast Asia by opening its 15th subsidiary...

Top Four Reasons Patients Adopt a Hospital-Branded Mobile...

A successful hospital mobile strategy must take a patientcentric approach to development and embrace the reality that patients are consumers with high expectations for the...

Five Strategies for Health Systems to Increase Patient...

With 65% of patient financial liabilities never collected bad debt is a massive problem for all health systems and providers. As high deductible plans rise in...

Diplomat taking measures to bring affordable brand medications

Diplomat Pharmacy, Inc. plans to combat rising healthcare costs throughout 2018 by advancing generic drugs, biosimilars, and affordable brand medications. Joel Saban, president of Diplomat, said...

QCCA on top, Becomes the first CIN in...

The board of the Quality Cancer Care Alliance (QCCA) voted unanimously in favor of becoming a clinically integrated network (CIN) on a national level, making...

LEED Gold Certification rewarded to Prolacta Bioscience® for...

Prolacta Bioscience, the nation's leading provider of human milk-based neonatal nutritional products to hospitals, announced today it has earned a Leadership in Energy and Environmental...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »